Generation of a variety of stable Influenza A reporter viruses by genetic engineering of the NS gene segment

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Reuther, Peter ^a   Göpfert, Kristina ^a   Dudek, Alexandra H ^a   Heiner, Monika ^b   Herold, Susanne ^b   Schwemmle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INS1 PROTEIN, INFLUENZA VIRUS; LUCIFERASE; VIRAL PROTEIN;

ANIMAL; BIOSYNTHESIS; DOG; GENETICS; HEK293 CELL LINE; HUMAN; INFLUENZA A VIRUS; MDCK CELL LINE; METABOLISM; MOUSE; REPORTER GENE;

ANIMALS; DOGS; GENES, REPORTER; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS; LUCIFERASES; MADIN DARBY CANINE KIDNEY CELLS; MICE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84931281975     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11346     Document Type: Article

References (57)

1. WHO, Fact sheet N°211-Influenza (seasonal), (2014) http://www.who.int/mediacentre/factsheets/fs211/en (Date of access: 30/12/2014
2. Horimoto, T. & Kawaoka, Y. Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Micro 3, 591-600; doi:10.1038/nrmicro1208 (2005
3. Gao, R. et al. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. New Engl. J. Med. 368, 1888-1897; doi:10.1056/NEJMoa1304459 (2013
4. Chan, P. K. S. Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997. Clin. Infect. Dis. 34, S58-S64; doi:10.1086/338820 (2002
5. Cox, N. J. & Subbarao, K. Influenza. The Lancet 354, 1277-1282; doi:10.1016/S0140-6736(99)01241-6 (1999
6. Moscona, A. Global Transmission of Oseltamivir-Resistant Influenza. New Engl. J. Med. 360, 953-956; doi:10.1056/NEJMp0900648 (2009
7. Bush, R. M., Bender, C. A., Subbarao, K., Cox, N. J. & Fitch, W. M. Predicting the Evolution of Human Influenza A. Science 286, 1921-1925; doi:10.1126/science.286.5446.1921 (1999
8. De Clercq, E. Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov. 5, 1015-1025; doi:10.1038/nrd2175 (2006
9. Lambert, L. C. & Fauci, A. S. Influenza Vaccines for the Future. New Engl. J. Med. 363, 2036-2044; doi:10.1056/NEJMra1002842 (2010
10. Sutton, T. C. et al. Genome rearrangement of influenza virus for anti-viral drug screening. Virus Res. 189, 14-23; doi:10.1016/j. virusres.2014.05.003 (2014
11. Heaton, N. S. et al. In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies. J. Virol. 87, 8272-8281; doi:10.1128/jvi.00969-13 (2013
12. Munier, S., Rolland, T., Diot, C., Jacob, Y. & Naffakh, N. Exploration of Binary Virus-Host Interactions Using an Infectious Protein Complementation Assay. Mol. Cell. Proteomics 12, 2845-2855; doi:10.1074/mcp.M113.028688 (2013
13. Tran, V., Moser, L. A., Poole, D. S. & Mehle, A. Highly Sensitive Real-Time In Vivo Imaging of an Influenza Reporter Virus Reveals Dynamics of Replication and Spread. J. Virol. 87, 13321-13329; doi:10.1128/jvi.02381-13 (2013
14. Pan, W. et al. Visualizing influenza virus infection in living mice. Nat Commun 4; doi:10.1038/ncomms3369 (2013
15. Eckert, N. et al. Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral Replication and Its Inhibition by Antiviral Compounds and Cellular Proteins. PLoS ONE 9, e97695; doi:10.1371/journal.pone.0097695 (2014
16. Manicassamy, B. et al. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 107, 11531-11536; doi:10.1073/pnas.0914994107 (2010
17. Avilov, S. V. et al. Replication-Competent Influenza A Virus That Encodes a Split-Green Fluorescent Protein-Tagged PB2 Polymerase Subunit Allows Live-Cell Imaging of the Virus Life Cycle. J. Virol. 86, 1433-1448; doi:10.1128/jvi.05820-11 (2012
18. Lakdawala, S. S. et al. Influenza A Virus Assembly Intermediates Fuse in the Cytoplasm. PLoS Pathog 10, e1003971; doi:10.1371/journal.ppat.1003971 (2014
19. Noda, T. et al. Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun 3, 639; doi:10.1038/ncomms1647 (2012
20. Kuznetsova, I. et al. Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector. J. Gen. Virol. 95, 337-349; doi:10.1099/vir.0.056036-0 (2014
21. Lamb, R. A. & Lai, C.-J. Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21, 475-485; doi:10.1016/0092-8674(80)90484-5 (1980
22. Sharma, P. et al. 2A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Res.; doi:10.1093/nar/gkr1176 (2011
23. Chua, M.A., Schmid, S., Perez, J.T., Langlois, R.A. & tenOever, B.R. Influenza A Virus Utilizes Suboptimal Splicing to Coordinate the Timing of Infection. Cell Reports 3, 23-29; doi:10.1016/j.celrep.2012.12.010.
24. Reuther, P., Giese, S., Götz, V., Riegger, D. & Schwemmle, M. Phosphorylation of Highly Conserved Serine Residues in the Influenza A Virus Nuclear Export Protein NEP Plays a Minor Role in Viral Growth in Human Cells and Mice. J. Virol. 88, 7668-7673; doi:10.1128/jvi.00854-14 (2014
25. Li, S. Q., Orlich, M. & Rott, R. Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes. J. Virol. 64, 3297-3303 (1990
26. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97, 6108-6113; doi:10.1073/pnas.100133697 (2000
27. Reuther, P. et al. Adaptive Mutations in the Nuclear Export Protein of Human-Derived H5N1 Strains Facilitate a Polymerase Activity-Enhancing Conformation. J. Virol. 88, 263-271; doi:10.1128/jvi.01495-13 (2014
28. Brunotte, L. et al. The Nuclear Export Protein of H5N1 Influenza A Viruses Recruits Matrix 1 (M1) Protein to the Viral Ribonucleoprotein to Mediate Nuclear Export. J. Biol. Chem. 289, 20067-20077; doi:10.1074/jbc.M114.569178 (2014
29. Paterson, D. & Fodor, E. Emerging Roles for the Influenza A Virus Nuclear Export Protein (NEP). PLoS Pathog 8, e1003019; doi:10.1371/journal.ppat.1003019 (2012
30. Mänz, B., Schwemmle, M. & Brunotte, L. Adaptation of Avian Influenza A Virus Polymerase in Mammals To Overcome the Host Species Barrier. J. Virol. 87, 7200-7209; doi:10.1128/jvi.00980-13 (2013
31. Mena, M. A., Treynor, T. P., Mayo, S. L. & Daugherty, P. S. Blue fluorescent proteins with enhanced brightness and photostability from a structurally targeted library. Nat Biotech 24, 1569-1571; doi:10.1038/nbt1264 (2006
32. Gabriel, G. et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl. Acad. Sci. USA 102, 18590-18595; doi:10.1073/pnas.0507415102 (2005
33. Koutsoudakis, G. et al. Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses. J. Virol. 80, 5308-5320; doi:10.1128/jvi.02460-05 (2006
34. Blair, W. S. et al. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors. Antiviral Res. 65, 107-116; doi:10.1016/j.antiviral.2004.11.001 (2005
35. Uebelhoer, L. S. et al. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res. 106, 86-94; doi:10.1016/j.antiviral.2014.03.018 (2014
36. Zou, G., Xu, H. Y., Qing, M., Wang, Q.-Y. & Shi, P.-Y. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res. 91, 11-19; doi:10.1016/j.antiviral.2011.05.001 (2011
37. Tannous, B. A. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat. Protocols 4, 582-591; doi:10.1038/nprot.2009.28 (2009
38. Wurdinger, T. et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Meth 5, 171-173; doi:10.1038/nmeth.1177 (2008
39. Turan, S. et al. Recombinase-Mediated Cassette Exchange (RMCE): Traditional Concepts and Current Challenges. J. Mol. Biol. 407, 193-221; doi:10.1016/j.jmb.2011.01.004 (2011
40. Sauer, B. & Henderson, N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85, 5166-5170 (1988
41. Koo, B.-K. et al. Controlled gene expression in primary Lgr5 organoid cultures. Nat Meth 9, 81-83; doi:10.1038/nmeth.1802 (2012
42. Yatim, N. & Albert Matthew, L. Dying to Replicate: The Orchestration of the Viral Life Cycle, Cell Death Pathways, and Immunity. Immunity 35, 478-490; doi:10.1016/j.immuni.2011.10.010 (2011
43. Sanders, C., Doherty, P. & Thomas, P. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res. 343, 13-21; doi:10.1007/s00441-010-1043-z (2011
44. Vreede, F. T. & Fodor, E. The role of the influenza virus RNA polymerase in host shut-off. Virulence 1, 436-439; doi:10.4161/viru.1.5.12967 (2010
45. Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593-605; doi:10.1002/dvg.20335 (2007
46. Heaton, N. S. et al. Long-term survival of influenza virus infected club cells drives immunopathology. J. Exp. Med. 211, 1707-1714; doi:10.1084/jem.20140488 (2014
47. Dos Santos Afonso, E., Escriou, N., Leclercq, I., Van Der Werf, S. & Naffakh, N. The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5? end of the PB2 segment. Virology 341, 34-46; doi:10.1016/j.virol.2005.06.040 (2005
48. Kumar, Pooja A. et al. Distal Airway Stem Cells Yield Alveoli In Vitro and during Lung Regeneration following H1N1 Influenza Infection. Cell 147, 525-538; doi:10.1016/j.cell.2011.10.001 (2011
49. Janda, J. M., Davis, A. R., Nayak, D. P. & De, B. K. Diversity and generation of defective interfering influenza virus particles. Virology 95, 48-58; doi:10.1016/0042-6822(79)90400-8 (1979
50. Huang, A. S. & Baltimore, D. Defective Viral Particles and Viral Disease Processes. Nature 226, 325-327; doi:10.1038/226325a0 (1970
51. Brooke, C. B. et al. Most Influenza A Virions Fail To Express at Least One Essential Viral Protein. J. Virol. 87, 3155-3162; doi:10.1128/jvi.02284-12 (2013
52. Von Magnus, P. Incomplete forms of influenza virus. Adv. Virus Res. 2, 59-79 (1954
53. Brooke, C. B. Biological activities of 'noninfectious' influenza A virus particles. Future virology 9, 41-51; doi:10.2217/fvl.13.118 (2014
54. Herrel, M., Hoefs, N., Staeheli, P. & Schneider, U. Tick-Borne Nyamanini Virus Replicates in the Nucleus and Exhibits Unusual Genome and Matrix Protein Properties. J. Virol. 86, 10739-10747; doi:10.1128/jvi.00571-12 (2012
55. Laemmli, U. K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 227, 680-685; doi:10.1038/227680a0 (1970
56. Unkel, B. et al. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J. Clin. Invest. 122, 3652-3664; doi:10.1172/JCI62139 (2012
57. McQualter, J. L., Yuen, K., Williams, B. & Bertoncello, I. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc. Natl. Acad. Sci. USA 107, 1414-1419; doi:10.1073/pnas.0909207107 (2010).